BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7692953)

  • 1. [Prediction of recurrence of gastrointestinal cancer from standpoint of biological malignancies--tumor marker doubling time and its a half life period line].
    Mai M; Takahashi Y
    Hum Cell; 1993 Jun; 6(2):82-7. PubMed ID: 7692953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
    Gebauer G; Müller-Ruchholtz W
    Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The preoperative and postoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of gastric cancer. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer].
    Sakamoto J; Nakazato H; Toge T; Mai M; Okura H; Kodaira S; Maetani S; Okajima K; Hattori T; Inokuchi K
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1095-104. PubMed ID: 2204669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastrointestinal cancer].
    Takahashi Y
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1275-9. PubMed ID: 15332558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The tumor markers CEA, AFP and CA125 in patients with endometrial carcinoma].
    Gorchev G; Milkov V; Popov I
    Akush Ginekol (Sofiia); 1992; 31(1):22-5. PubMed ID: 1285257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of tumor markers in colorectal cancer].
    Peters KM; Grundmann R
    Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of tumor markers in the treatment of patients with ovarian malignancies].
    Tomoda Y; Kano T; Furuhashi Y; Mizuno K; Kamiya N; Mizuno K; Sakakibara K; Ohta M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3027-33. PubMed ID: 2445293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
    Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
    Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of the new tumor marker TAG-72.
    Guadagni F; Roselli M; Ferroni P; Amato T; Colcher D; Greiner JW; Schlom J
    Anticancer Res; 1991; 11(4):1389-94. PubMed ID: 1746895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs].
    Ishii M
    Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of skeletal metastases by serum tumor markers].
    Shinozaki T; Chigira M
    Nihon Seikeigeka Gakkai Zasshi; 1991 Aug; 65(8):441-6. PubMed ID: 1720162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
    Schmidt P; Thiele M; Rudroff C; Vaz A; Schilli M; Friedrich K; Scheele J
    Hepatogastroenterology; 2001; 48(42):1675-9. PubMed ID: 11813599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
    Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
    Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers in the upper intestinal tract--stomach and pancreas].
    Pointner R; Conrad F; Schwab G
    Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of clinical course and recurrence of human ovarian cancer by several serum tumor markers.
    Kikuchi Y; Kita T; Iwano I; Kuki E; Oomori K; Kizawa I
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):69-76. PubMed ID: 2926196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers in gastrointestinal malignancies.
    Cooper EH; de Mello Júnior JP; Giles GR
    Arq Gastroenterol; 1989; 26(4):131-40. PubMed ID: 2484747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.